RKLB · Rocket Lab

114 filings

RKLB SEC Filings

Rocket Lab - 114 total filings

Filing record · 2020–202610-K810-Q188-K88

Showing 1–50 of 114 filings

Rocket Lab 8-K Report, Regulation FD Disclosure (Oct 14, 2026)

Rocket Lab (RKLB) furnished an 8-K on October 14, 2026 disclosing an update to its Neutron medium-lift rocket program. The company now expects the inaugural Neutron launch to occur in 2027, rather than the previously anticipated timeframe, which it attributes to continued development work and the incorporation of process improvements. Management says the program is progressing through key manufacturing and testing milestones. The update was issued as a press release (Exhibit 99.1) and accompanied by an investor presentation on the company's investor relations website. For investors, the central takeaway is a delay in the timing of Neutron's first flight. Neutron is a central pillar of Rocket Lab's growth narrative as a reusable medium-lift vehicle that would extend the company beyond its Electron and HASTE small-lift business, so slippage affects the timing of expected Neutron revenue and the broader medium-lift opportunity. The filing does not quantify any financial impact, revised revenue expectations, updated cost estimates, or changes to guidance, so those details would need to come from the accompanying presentation or future earnings disclosures. The filing is a Regulation FD disclosure with Items 7.01 and 8.01, and the company states that the information is furnished rather than filed for Section 18 purposes. The company has not provided a new specific launch date and has committed only to further updates as work continues. Investors should watch for those updates, the detailed presentation, and any changes to the company's forward-looking financial commentary.

Oct 14, 2026 8-K

Rocket Lab 8-K Report, Regulation FD Disclosure (Sep 15, 2026)

Rocket Lab (RKLB) reported on September 15, 2026 that it has fully funded its pending acquisition of Iridium Communications. The company completed its at-the-market (ATM) equity program, raising approximately $1.944 billion in gross proceeds from the sale of about 29.3 million shares before commissions and expenses. Management says these proceeds, together with the amended Iridium credit facility and other available liquidity, are sufficient to cover the anticipated cash consideration and related payments at closing. The company expects the transaction to close in mid-2027, subject to regulatory approvals and stockholder approval of the Iridium holders. On the debt side, Iridium and its lenders (at least the Required Lenders) signed Consent and Amendment No. 4 to the existing $1.775 billion term loan. The amendment carves the Transaction out of the change-of-control definition, so the loans can remain outstanding after closing, and it adds a downstream unsecured guarantee from Rocket Lab USA, Inc. at closing. Post-closing pricing steps up to SOFR plus 2.50%-3.00% (or base rate plus 1.50%-2.00%) based on Rocket Lab's credit ratings, and a 1.00% exit fee applies to prepayments after the first anniversary of closing. The $3.6 billion 364-day bridge commitment was terminated in full, removing a bridge-financing overhang. For investors, the key takeaways are reduced financing risk and a clearer capital structure, offset by meaningful dilution from the ATM issuance and a higher cost of the permanent Iridium debt once the deal closes. The filing does not disclose Iridium's or Rocket Lab's standalone financial results, purchase price breakdown, or pro forma leverage, so those figures should be sought in the S-4/final prospectus.

Sep 15, 2026 8-K

Rocket Lab 8-K Report, Regulation FD Disclosure (Aug 13, 2026)

Rocket Lab (RKLB) disclosed a replacement at-the-market (ATM) equity program with Deutsche Bank Securities and Wells Fargo Securities, under which it may sell common stock with an aggregate offering price of up to $1,944,369,826. The new agreement replaces the prior equity distribution agreement dated May 20, 2026, and carries forward the unsold amount under that program rather than adding capacity. The company also may enter into forward sale agreements, including initially priced and collared forward transactions. Sales commissions are capped at 2.00% of gross proceeds, and the program may be terminated on two days' notice. The company says the net proceeds will fund cash payments for its proposed acquisition of Iridium Communications and reduce its committed bridge facility. The offering is not conditioned on completing the Iridium deal, and the company says it will use any excess proceeds for growth, potential acquisitions, and general corporate purposes. A concurrent press release on the Iridium acquisition reports several milestones. The Hart-Scott-Rodino waiting period expired at 11:59 p.m. ET on August 12, 2026, which clears U.S. antitrust review. Rocket Lab filed its Form S-4 registration statement, which is not yet effective, and FCC transfer-of-control applications were filed on August 10, 2026. The company holds a $3.6 billion 364-day senior secured bridge commitment and plans to replace it with permanent debt and equity. It also intends to seek lender consents to amend Iridium's $1.775 billion term loan so that facility can stay in place, which would reduce the bridge commitment. There is no assurance those consents will be obtained. For investors, the key points are the scale of potential dilution, the reliance on equity and debt refinancing to fund a large acquisition, and the execution risk tied to lender consents, S-4 effectiveness, and shareholder approvals. Because the ATM sales can be suspended at any time and are subject to price and volume parameters, the timing and size of actual issuance are uncertain. Investors should monitor future prospectus supplements, the S-4 review process, and any Iridium lender consent results.

Aug 13, 2026 8-K

Rocket Lab 8-K Report, Corporate Update (Aug 13, 2026)

Rocket Lab (RKLB) filed this Form 8-K on August 13, 2026 to furnish financial information tied to its pending acquisition of Iridium Communications (IRDM), agreed June 28, 2026. Under the Merger Agreement, Iridium holders would receive $27.00 in cash plus Rocket Lab stock at a floating exchange ratio: 0.4000 shares if Rocket Lab's 10-day VWAP is at or below $67.50, 0.2400 at or above $112.50, and $27.00 divided by the VWAP in between. Using the 10-day VWAP ending August 7, 2026 of $69.33, the exchange ratio is 0.3894, implying about 41.3 million new Rocket Lab shares and an estimated total purchase consideration of roughly $7.59 billion. The filing itself contains no new operating guidance; its substance is the Iridium audited and unaudited financials (incorporated by reference) and the pro forma combined statements. The pro forma statements show the financing burden clearly. The deal is funded with a $3.6 billion 364-day bridge facility at an effective rate of about 8.0%, which the filing says Rocket Lab intends to replace with permanent financing, though terms are not yet determinable. Pro forma combined cash falls to about $1.0 billion from $2.1 billion at June 30, 2026, and pro forma interest expense rises to about $143 million for the six months ended June 30, 2026 and $312 million for FY2025. On a pro forma basis, Rocket Lab's combined results show a six-month net loss of $154.7 million (EPS of -$0.23) and a FY2025 net loss of $203.0 million (EPS of -$0.36), compared with standalone Rocket Lab net losses of $94.3 million and $198.2 million. Pro forma combined revenue is about $879 million for the six months and $1.47 billion for FY2025. The filing also flags several uncertainties: preliminary purchase price allocation with about $2.2 billion of goodwill and $4.3 billion of intangibles (subject to change), a tax-free reorganization treatment that depends on the cash-to-stock mix, a possible reduction in bridge borrowings if Iridium debt amendments are completed, and the acquisition of Aireon by Iridium on July 2, 2026, which adds debt not reflected in these figures. The transaction remains subject to Iridium stockholder approval, regulatory approvals, and the effectiveness of the Form S-4.

Aug 13, 2026 8-K

Rocket Lab 8-K Report, Financial Results (Aug 10, 2026)

Rocket Lab reported record second-quarter 2026 revenue of $234.1 million, up 62% year-over-year and $34 million above the prior quarter, with record backlog of $2.36 billion (up 137% year-over-year). GAAP net loss narrowed to $49.3 million from $66.4 million a year earlier, and Adjusted EBITDA improved to a loss of $8.8 million from a loss of $27.6 million. GAAP gross margin was about 36.1% (84.6 million on 234.1 million of revenue), while the company reported a non-GAAP gross margin of 41.5%. GAAP operating expenses rose to $142.1 million, driven by higher R&D and SG&A, including $8.6 million of transaction costs. Management said new contracts of more than $1 billion had been signed in Q3 to date, including a $397 million SB-AMTI launch-plus-spacecraft award from the U.S. Space Force. The balance sheet changed substantially. Cash and equivalents rose to $2.13 billion from $829 million at year-end 2025, largely because of $1.53 billion in at-the-market (ATM) equity proceeds in the first half. Shares outstanding increased to about 598 million from about 544 million. Operating cash flow was negative $134 million for the six months, and inventories and receivables grew sharply, reflecting the ramp in production and contract activity. Contract liabilities of $351 million, up from $195 million, indicate substantial customer prepayments supporting the backlog. For Q3 2026, management guided to revenue of $250 million to $265 million, GAAP gross margin of 29% to 31%, non-GAAP gross margin of 35% to 37%, and an Adjusted EBITDA loss of $17 million to $23 million. The company also announced a landmark agreement to acquire Iridium Communications, which would vertically integrate launch, satellite manufacturing, and constellation operations. The Iridium deal, the Neutron first launch timeline (target delivery to the pad in Q4 2026), and the Neutron execution risk are the key items for investors to monitor.

Aug 10, 2026 10-Q

Rocket Lab Quarterly Report for Q2 Ended Jun 30, 2026

Rocket Lab Corporation (RKLB) has reported a significant increase in total revenues for the six months ended June 30, 2026, reaching $434.4 million, a 63% rise year-over-year. This growth is primarily driven by a 76% increase in Space Systems revenue, fueled by satellite manufacturing and strategic acquisitions, complemented by a 32% rise in Launch Services revenue attributed to higher launch cadence and revenue per launch. The company's financial position has strengthened considerably, with cash and cash equivalents and marketable securities totaling $2.39 billion as of June 30, 2026, up from $1.10 billion at the end of 2025. This robust liquidity, coupled with substantial order backlog of $2.36 billion, positions Rocket Lab well for its ambitious growth plans. The company is actively pursuing strategic growth initiatives, including the significant development of its Neutron launch vehicle, with production aligned for a potential Q4 2026 launch. Furthermore, Rocket Lab announced a definitive agreement to acquire Iridium Communications Inc. for approximately $8.0 billion, expected to close in 2027, which would substantially expand its capabilities and market reach. Recent contract wins, including a potential $266 million U.S. Space Force contract for suborbital launches and a $397 million contract for satellites, further underscore the company's strong market position and future revenue potential.

Aug 10, 2026 8-K

Rocket Lab 8-K Report, Material Agreement (Jun 29, 2026)

Rocket Lab (RKLB) has agreed to acquire Iridium Communications (IRDM) in a cash-and-stock merger valued at a notional $54.00 per Iridium share, or an enterprise value of about $8.0 billion. Each Iridium share will receive $27.00 in cash plus Rocket Lab stock under a collared exchange ratio: 0.4000 shares if RKLB's 10-day VWAP is at or below $67.50, a fixed-value ratio of $27.00 divided by the VWAP between $67.50 and $112.50, and 0.2400 shares at or above $112.50. Within the collar, the stock component is worth a fixed $27.00, so Iridium holders are protected from RKLB price moves in that band. Outside it, the value floats: below $67.50 the stock component is worth less than $27.00, and above $112.50 it is worth more. The transaction is structured as a two-step merger intended to qualify as a tax-free reorganization, though that treatment depends on the cash-to-stock value mix at closing. The deal is financed in part by a $3.6 billion 364-day senior secured bridge loan from Deutsche Bank and Wells Fargo, with the balance of the cash component to come from Rocket Lab's balance sheet and other debt or equity sources. Rocket Lab's cash position and leverage will therefore change materially if the deal closes, and the filing does not quantify the total cash requirement or post-closing leverage. Completion requires Iridium stockholder approval, HSR clearance, FCC consent for the transfer of control of Iridium's telecom authorizations, several foreign investment and satellite approvals, and an effective Form S-4 registration covering the RKLB shares to be issued. The outside date is June 28, 2027, extendable to September and December 2027. Iridium owes Rocket Lab a $223.62 million termination fee in specified circumstances, including a superior proposal or an adverse board recommendation change. Iridium's 2025 revenue was $871.7 million with OEBITDA of $495 million (57% margin), per the companies, which Rocket Lab frames as a source of recurring cash flow and accretion. Directors holding about 1.6% of Iridium shares have signed support agreements. Management expects closing in mid-2027.

Jun 29, 2026 8-K

Rocket Lab 8-K Report, Executive Changes (Jun 5, 2026)

Rocket Lab Corporation (RKLB) announced a significant leadership change within its finance department through an 8-K filing on June 5, 2026. The company appointed Agostino Ricupati as Vice President, Corporate Controller and Chief Accounting Officer, effective June 3, 2026. Mr. Ricupati brings extensive experience from senior finance and accounting roles at large, publicly traded multinational corporations, including over two decades at Cooper Companies and prior roles at Intel, McAfee, Baxter International, and Arthur Andersen LLP. His appointment is expected to strengthen the company's global accounting operations. This appointment also means Adam C. Spice will transition from his role as principal accounting officer, though he will continue as Chief Financial Officer and principal financial officer. The filing details Mr. Ricupati's compensation package, which includes a base salary of $350,000, potential performance bonuses, a $50,000 sign-on bonus, a temporary housing stipend, and a substantial $3 million restricted stock unit award vesting over four years. Investors should view this as a strategic move to bolster financial oversight and reporting capabilities as Rocket Lab continues its growth trajectory.

Jun 5, 2026 8-K

Rocket Lab 8-K Report, Shareholder Vote Results (May 21, 2026)

Rocket Lab Corp (RKLB) held its 2026 Annual Meeting of Stockholders on May 20, 2026, where several key proposals were voted upon by shareholders. The results indicate strong support for the company's leadership and strategic direction. Notably, all proposals presented received overwhelming approval, suggesting shareholder confidence in the company's management and operational plans. Investors should note the election of Edward H. Frank as a Class II director, the ratification of Deloitte & Touche LLP as the independent auditor for fiscal year 2026, and the approval of executive compensation on an advisory basis. A significant proposal that passed overwhelmingly was the approval of a subsidiary merger aimed at streamlining certain corporate actions by eliminating a pass-through voting provision related to Rocket Lab USA, Inc. This move is likely intended to enhance operational flexibility and decision-making efficiency.

May 21, 2026 8-K

Rocket Lab 8-K Report, Corporate Update (May 20, 2026)

Rocket Lab Corporation has entered into an Equity Distribution Agreement with a syndicate of prominent financial institutions, allowing for the potential sale of up to $3 billion of its common stock. This agreement enables the company to raise capital flexibly through various equity financing methods. A key aspect of this arrangement is the incorporation of forward sale agreements, which allow Rocket Lab to potentially receive proceeds from stock sales at a future date, with specific mechanisms designed for both "Initially Priced Forward Transactions" and "Collared Forward Transactions." These forward sale structures offer different pricing mechanisms and settlement options, including potential cash or stock settlements. The "Collared Forward Transactions" introduce a floor and cap price for sales, providing some protection against extreme price volatility during the hedging period. The company retains the right to specify certain trading parameters and to suspend sales under specific conditions, offering a degree of control over the execution. The agreement is underpinned by an effective shelf registration statement, indicating readiness for capital deployment.

May 20, 2026 8-K

Rocket Lab 8-K Report, Corporate Update (May 8, 2026)

Rocket Lab Corporation (RKLB) filed an 8-K on May 8, 2026, primarily detailing the filing of a prospectus supplement related to the resale of shares. These shares, totaling up to 2,277,002, were issued on April 14, 2026, in a private placement connected to the acquisition of Mynaric AG. The filing ensures these shares, previously issued under the Stock Purchase Agreement dated September 25, 2025, can be legally resold by certain selling stockholders. This filing is important for investors as it clarifies the process for secondary market liquidity for a specific block of RKLB shares. While not a direct financial event for the company itself, it signals the completion of a key step in the Mynaric AG acquisition by enabling the resale of shares issued as consideration. Investors should note that the shares are being resold by existing stockholders, not newly issued by the company. The company also included a legal opinion from Goodwin Procter LLP as an exhibit to support the prospectus supplement.

May 8, 2026 10-Q

Rocket Lab Quarterly Report for Q1 Ended Mar 31, 2026

Rocket Lab Corporation (RKLB) reported significant revenue growth of 63% for the first quarter of 2026, reaching $200.3 million, driven by strong performance in both its Launch Services and Space Systems segments. The company's balance sheet shows a healthy increase in cash and cash equivalents to $1.2 billion, up from $828.7 million at the end of 2025, providing substantial liquidity. Despite the revenue surge, RKLB continued to invest heavily in research and development, particularly for the Neutron launch vehicle, leading to an operating loss of $56.0 million. However, the significant revenue increase and improved gross profit margin to 38.2% (up from 28.8% in Q1 2025) indicate positive operational leverage. Key developments include ongoing progress on the Neutron launch vehicle, which is on track for its debut launch later in the year, though risks and uncertainties remain. The company also successfully closed the acquisition of GEOST LLC in August 2025, integrating new capabilities into its Space Systems segment. While the company continues to operate at a net loss, the substantial revenue growth, strong cash position, and strategic investments in future growth drivers like Neutron position RKLB for potential long-term value creation, though investors should remain mindful of the ongoing R&D expenditures and development risks.

May 7, 2026 8-K

Rocket Lab 8-K Report, Financial Results (May 7, 2026)

Rocket Lab (RKLB) reported first-quarter 2026 results that management characterized as a record quarter across revenue, gross margin, and backlog. Revenue reached $200.3M, up 63.5% year over year from $122.6M, and GAAP gross margin expanded to 38.2% (from roughly 28.8% a year earlier). GAAP operating loss narrowed to $55.97M from $59.19M, and net loss improved to $45.0M, or $(0.07) per share, versus $60.6M, or $(0.12), in Q1 2025. Adjusted EBITDA was $(11.8)M, compared with $(30.0)M a year earlier. Backlog rose 20.2% quarter over quarter to $2.2B, and the company cited more than $2B of total liquidity following an at-the-market equity program. The balance sheet strengthened substantially: cash and equivalents rose to $1.21B from $829M, largely from $450M of ATM equity proceeds, and the convertible senior notes fell to $36.9M from $152.4M, likely reflecting conversion or repayment. Operating cash flow was still negative at $(50.3)M, and inventories, receivables, and contract assets all grew, so working-capital needs are rising alongside growth. Share count increased as well, with outstanding common shares rising to about 576M from 544M. Looking ahead, management guided Q2 2026 revenue to $225–240M, GAAP gross margin to 33–35%, and adjusted EBITDA loss to $20–26M. The guidance implies lower GAAP gross margin than Q1 and a wider EBITDA loss, which investors will likely scrutinize. Key strategic items include the Mynaric acquisition (closed), a pending Motiv acquisition, selection for the Space Based Interceptor program under Golden Dome, and the Neutron medium-lift rocket's targeted debut later in 2026. Neutron timing and margin trajectory remain the central execution risks.

May 7, 2026 8-K

Rocket Lab 8-K Report, Unregistered Securities Sale (Apr 14, 2026)

On April 14, 2026, Rocket Lab Corporation (Nasdaq: RKLB) completed its acquisition of Mynaric AG, a Munich-based provider of laser optical communication terminals, for an aggregate consideration value of $155.3 million. The consideration consisted of a nominal cash payment and 2,277,002 shares of Rocket Lab common stock, of which 109,943 shares were placed in an indemnity escrow. The purchase price was based on a $75 million base price plus additional investments made by the Sellers (OC III LVS LIII LP and CO Finance II LVS I LLC) prior to closing, which reduced the earnout the Sellers could otherwise have received. Subject to post-closing adjustments, the Sellers are no longer eligible for further earnout payments. The deal received approval from Germany's Federal Ministry for Economic Affairs and Energy. Strategically, the acquisition adds laser communications to Rocket Lab's space systems portfolio and establishes its first European footprint, with Mynaric remaining headquartered in Munich. Management highlighted that Mynaric supplies CONDOR Mk3 optical terminals for Rocket Lab's $1.3 billion SDA Proliferated Warfighter Space Architecture prime contracts (36 satellites), which gave the company detailed insight into the technology and its scaling potential. Management plans to expand Mynaric's production capacity to address supply-chain bottlenecks in satellite laser communications. The filing is largely administrative, and the 8-K does not provide revenue, margin, or profitability figures for Mynaric, nor a detailed purchase price allocation. Investors should note the dilution from the 2,277,002 newly issued shares, which were issued under a private placement exemption (Section 4(a)(2) / Regulation D), and should look to upcoming filings and earnings commentary for Mynaric's financial contribution and integration costs.

Apr 14, 2026 8-K

Rocket Lab 8-K Report, Executive Changes (Mar 30, 2026)

Rocket Lab Corporation (RKLB) filed an 8-K on March 30, 2026, detailing significant changes to its CEO, Sir Peter Beck's, compensation. In a move demonstrating strong commitment to shareholder value and disciplined fiscal management, Mr. Beck has voluntarily agreed to reduce his annual base salary to $1.00 or the statutory minimum, and has waived any entitlement to an annual bonus. Furthermore, Mr. Beck has forfeited all unvested Restricted Stock Units (RSUs) representing 392,155 shares. This decision will redirect capital previously allocated for his compensation towards the Company's strategic research and development (R&D) initiatives and other corporate priorities. This aligns with the company's focus on long-term appreciation of shareholder value, as opposed to short-term incentives.

Mar 30, 2026 8-K

Rocket Lab 8-K Report, Corporate Update (Mar 17, 2026)

Rocket Lab Corporation has entered into an Equity Distribution Agreement, allowing it to sell up to $1 billion of its common stock over time through various sales agents. This agreement also enables the company to utilize forward sale agreements, a mechanism that allows for the potential sale of stock at a future date, with initial hedging activities managed by designated forward sellers. This move provides Rocket Lab with significant flexibility to access capital, potentially raising substantial funds to support its ongoing operations and growth initiatives. The agreement outlines two primary types of forward transactions: Initially Priced Forward Transactions and Collared Forward Transactions. In the former, the company will receive proceeds at a later settlement date based on an initial forward sale price. The latter involves a more complex structure where the sale price is determined by a range (floor and cap) based on initial hedging activity, with potential for prepaid amounts and eventual settlement. Investors should note that the company does not immediately receive proceeds from the initial sale of borrowed shares in forward transactions. The company's ability to execute these sales is subject to market conditions and the terms of the agreement, with sales potentially being suspended.

Mar 17, 2026 8-K

Rocket Lab 8-K Report, Shareholder Nominations (Mar 12, 2026)

Rocket Lab Corporation (RKLB) has filed an 8-K to provide notice regarding its 2026 Annual Meeting of Stockholders, scheduled for May 20, 2026. A key takeaway for investors is the deadline for submitting shareholder proposals and director nominations. Due to the date change for the annual meeting compared to the previous year, proposals intended for inclusion in the company's proxy materials under Rule 14a-8 must be received by the Company Secretary no later than March 22, 2026. This announcement is crucial for any shareholder wishing to propose resolutions or nominate candidates for the board. Investors should note that these submissions must adhere not only to SEC rules but also to Rocket Lab's Amended and Restated Bylaws. The filing specifies the address for these submissions and emphasizes that failure to comply with the outlined requirements may result in proposals being omitted from the proxy materials. While this 8-K does not disclose new financial or operational performance data, it sets important procedural deadlines for shareholder engagement.

Mar 12, 2026 8-K

Rocket Lab 8-K Report, Financial Results (Feb 26, 2026)

Rocket Lab (RKLB) reported record fourth-quarter 2025 revenue of $179.7 million, up 36% year over year from $132.4 million, and record full-year 2025 revenue of $601.8 million, up 38% from $436.2 million. Gross profit rose to $207.2 million for the year, a GAAP gross margin of 34.4% (up from 26.6% in 2024), and non-GAAP gross margin reached 39.7%. Backlog grew 73% year over year to $1.85 billion, led by the $816 million Space Development Agency contract to build 18 missile warning and tracking satellites. Management also highlighted 21 Electron and HASTE launches in 2025 with a 100% mission success rate and several acquisitions in optical payloads and precision manufacturing. Profitability remains negative. The full-year GAAP net loss widened to $198.2 million (EPS of -$0.37), and adjusted EBITDA was a loss of $101.2 million. Operating expenses grew sharply, with Q4 R&D reaching $78.8 million versus $48.3 million a year earlier, reflecting Neutron development spending. The balance sheet was substantially strengthened through an at-the-market equity program that raised roughly $1.12 billion net in 2025, lifting cash and marketable securities to about $1.10 billion at year-end. Convertible senior notes fell from $345 million to $152 million on the balance sheet. The key forward-looking item is a Neutron schedule slip: first launch is now targeted for Q4 2026 following a stage 1 tank test failure. For Q1 2026, management guided revenue of $185-200 million (midpoint implying about 57% year-over-year growth), GAAP gross margin of 34-36%, and an adjusted EBITDA loss of $21-27 million. Investors will focus on Neutron execution, the pace of backlog conversion, and whether margins continue to improve as the business scales.

Feb 26, 2026 10-K

Rocket Lab Annual Report, Year Ended Dec 31, 2025

Rocket Lab Corporation (RKLB) has demonstrated significant growth in its 2025 fiscal year, with revenues increasing by 38% to $601.8 million. This expansion was driven by strong performance in both its Launch Services and Space Systems segments. The company's focus on vertical integration and technological innovation, including its 3D-printed Rutherford engines and carbon composite structures, continues to be a core strength. Despite a substantial increase in research and development expenses, primarily related to the development of the Neutron launch vehicle, Rocket Lab is strategically positioning itself for future growth in the expanding space economy. However, the company is still operating at a net loss, reporting a net loss of $198.2 million for 2025, indicating ongoing investment in product development and operational scaling. A key development highlighted is an issue encountered during Neutron's first stage tank qualification testing in January 2026, which has pushed the targeted first launch to Q4 2026. Investors should monitor the progress of Neutron and the company's ability to manage its significant R&D spend while moving towards profitability.

Feb 26, 2026 8-K

Rocket Lab 8-K Report, Regulation FD Disclosure (Jan 22, 2026)

Rocket Lab (RKLB) filed an 8-K on January 22, 2026 disclosing, via a press release dated January 21, 2026, that qualification testing of the Stage 1 tank for its Neutron medium-lift rocket ruptured during a hydrostatic pressure trial. The filing is furnished under Item 7.01 (Regulation FD, not deemed filed) and Item 8.01 (Other Events), and it contains no financial results, guidance changes, or quantified costs. Management characterizes the failure as a normal part of qualification testing, noting that the test structure and facilities sustained no significant damage and that the next Stage 1 tank is already in production. The company states that Neutron's development campaign continues while the team assesses the outcome. However, the impact on the launch schedule has not been determined. The team is still reviewing Stage 1 test data, and management intends to provide a Neutron schedule update on the Q4 2025 earnings call in February. For investors, the key takeaway is schedule risk rather than immediate financial impact. Neutron is central to Rocket Lab's medium-launch and constellation strategy, so any delay could affect the timing of revenue and the company's longer-term growth narrative. Investors should watch the February earnings call for a revised timeline, any cost or charge implications, and the results of the Stage 1 data review.

Jan 22, 2026 8-K

Rocket Lab 8-K Report, Regulation FD Disclosure (Dec 19, 2025)

Rocket Lab (RKLB) disclosed on December 19, 2025 that its wholly owned subsidiary, Rocket Lab USA, Inc., entered into a contract on December 17, 2025 with the U.S. Space Development Agency (SDA) to design, manufacture, and provide operations and sustainment for 18 satellites for the Tracking Layer Tranche 3 (TRKT3) program under the Proliferated Warfighter Space Architecture. The contract has a total stated value of $816 million, consisting of an $806 million base amount and options. The company describes it as its largest single contract to date. Work begins immediately, with final satellite delivery for launch expected in 2029. For investors, the award is significant because it adds a large, multi-year national security revenue stream and increases the company's total SDA awards to more than $1.3 billion, including the existing $515 million Transport Layer-Beta Tranche 2 contract. Management also states that Rocket Lab supplies payloads and components to other TRKT3 prime contractors, including its StarLite sensors, and estimates total capture value could reach about $1 billion once those subsystem opportunities are included. These subsystem figures are management estimates, not contracted amounts. Key risks include the agreement's termination-for-convenience provision, which allows either party to end the contract at any time subject to conditions, and the long delivery timeline to 2029, which leaves room for schedule and execution risk. The 8-K's options figure ($10 million) differs slightly from the press release's "up to $10.45 million," so investors should confirm the exact option value in the full contract documentation.

Dec 19, 2025 8-K

Rocket Lab 8-K Report, Financial Results (Nov 10, 2025)

Rocket Lab (RKLB) reported record third-quarter 2025 revenue of $155.1 million, up 48% year-over-year from $104.8 million, with GAAP gross margin of 37% (GAAP gross profit of $57.3 million versus $28.0 million a year earlier). Operating loss widened to $59.0 million from $51.9 million as operating expenses grew 46% to $116.3 million, driven by higher R&D (up to $70.7 million) and SG&A (up to $45.6 million), including $5.1 million of transaction costs tied to acquisitions. Net loss narrowed sharply to $18.3 million, or $0.03 per share, from $51.9 million, primarily because of a $41.1 million income tax benefit. Adjusted EBITDA was a loss of $26.3 million, compared with a loss of $30.9 million in the prior-year quarter. Balance sheet strength improved materially. Cash and cash equivalents rose to $807.9 million from $271.0 million at year-end 2024, and management states total liquidity exceeds $1 billion after the at-the-market equity program, which raised $865.5 million gross during the first nine months. Total assets grew to $2.22 billion, with goodwill and intangibles rising substantially after the Geost acquisition (up to $325 million, cash plus equity) and the Mynaric restructuring. Cash burn remains significant: net cash used in operating activities was $101.0 million for the nine months, and capital expenditures were $106.6 million, largely related to Neutron and Launch Complex 3 buildout. For Q4 2025, management guided to revenue of $170 million to $180 million, GAAP gross margin of 37% to 39%, and adjusted EBITDA loss of $23 million to $29 million, and expects to surpass its prior annual launch record and reach 20+ launches for the year. Neutron is now expected to arrive at Launch Complex 3 in Q1 2026, with first launch thereafter pending qualification testing. The 8-K also discloses that director Matt Ocko resigned from the board effective November 30, 2025, with no disagreement with the company cited.

Nov 10, 2025 10-Q

Rocket Lab Quarterly Report for Q3 Ended Sep 30, 2025

Rocket Lab Corporation (RKLB) reported a significant increase in revenue for the third quarter of 2025, reaching $155.1 million, a 48% rise year-over-year, driven by robust growth in both its Launch Services and Space Systems segments. For the nine-month period ending September 30, 2025, total revenue grew to $422.1 million, up 39% compared to the same period in 2024. Despite revenue growth, the company continued to operate at a net loss, with a loss of $18.3 million in the third quarter and $145.3 million for the first nine months of 2025. The company's cash position strengthened considerably, with cash and cash equivalents and marketable securities totaling over $1 billion as of September 30, 2025, a substantial increase from the previous year, largely due to successful equity offerings. Strategic acquisitions, notably the GEOST acquisition in August 2025, have contributed to the expansion of its Space Systems segment and the associated goodwill and intangible assets. Rocket Lab also announced plans to acquire Mynaric AG for $75 million, subject to regulatory approval, further bolstering its capabilities. While investing heavily in research and development, particularly for the Neutron launch vehicle, the company faces ongoing operational challenges including the impact of the US government shutdown, which has caused delays in contract awards and payments. Management anticipates that existing cash reserves will be sufficient to meet working capital needs for the next twelve months.

Nov 10, 2025 8-K

Rocket Lab 8-K Report, Unregistered Securities Sale (Sep 25, 2025)

Rocket Lab Corporation has announced a significant acquisition, entering into a Stock Purchase Agreement to acquire all outstanding ordinary shares of Mynaric AG, a German-based company. This strategic move is valued at an aggregate of $75 million, with the consideration payable in either cash or Rocket Lab's common stock at the company's discretion. The deal also includes potential post-closing earnout payments of up to $75 million, contingent on Mynaric's revenue performance in 2025, 2026, and 2027, also payable in cash or stock. The acquisition, if completed, represents a substantial expansion for Rocket Lab, integrating Mynaric's business into its operations. The consideration for the transaction, including any stock issued, will be made under exemptions from registration requirements, specifically Section 4(a)(2) of the Securities Act of 1933. Rocket Lab has committed to filing a resale registration statement for any shares issued in the transaction within 30 days post-closing, providing liquidity assurances for those receiving stock. The transaction is subject to customary closing conditions and regulatory approval from the German Ministry of Foreign Affairs.

Sep 25, 2025 8-K

Rocket Lab 8-K Report, Corporate Update (Sep 15, 2025)

Rocket Lab Corporation has entered into a new At-the-Market (ATM) Equity Offering Sales Agreement with a syndicate of well-known financial institutions, allowing it to sell up to $750 million worth of its common stock. This move follows the termination of a previous ATM sales agreement. The company is not obligated to sell any shares, but this provides flexibility to raise capital opportunistically through its effective shelf registration statement. Investors should view this as a tool for potential future funding needs, rather than an immediate indication of financial distress. The termination of the prior agreement and the establishment of this new, larger facility suggest a strategic decision to maintain access to equity markets. The substantial size of the offering indicates Rocket Lab's preparedness for potential capital requirements related to its ambitious growth plans in the space sector, including launch services and satellite components. The use of multiple sales agents diversifies execution capabilities and potentially optimizes pricing.

Sep 15, 2025 8-K

Rocket Lab 8-K Report, Executive Changes (Aug 29, 2025)

Rocket Lab Corporation (RKLB) filed an 8-K on August 29, 2025, detailing key governance and stockholder decisions made during its 2025 Annual Meeting of Stockholders on August 27, 2025. A significant development is the adoption of a Senior Executive Cash Incentive Bonus Plan by the Compensation Committee, designed to incentivize leadership through performance-based bonuses tied to corporate financial and operational goals, as well as individual performance. This plan aims to align executive compensation with the company's strategic objectives and performance metrics. Additionally, the filing reports the outcomes of several stockholder proposals. Directors Jon Olson, Merline Saintil, and Alex Slusky were elected to the Board of Directors. The appointment of Deloitte & Touche LLP as the independent registered public accounting firm for fiscal year 2025 was ratified. Stockholders provided advisory approval for the compensation of named executive officers. However, a proposed amendment to the Amended and Restated Certificate of Incorporation of Rocket Lab USA, Inc., intended to eliminate a pass-through voting provision, did not receive the required supermajority vote for approval.

Aug 29, 2025 8-K

Rocket Lab 8-K Report, Regulation FD Disclosure (Aug 12, 2025)

Rocket Lab (RKLB) reported in this 8-K, dated August 12, 2025, that its wholly-owned subsidiary Rocket Lab USA, Inc. closed its previously announced acquisition of the parent holding company of GEOST LLC, a developer of electro-optical and infrared (EO/IR) sensor systems for national security space missions. The total headline value was $275 million before closing adjustments, consisting of $125 million in cash and 3,057,588 shares of common stock, plus an additional earnout of up to $50 million in cash tied to future GEOST revenue targets. The deal was first announced on May 27, 2025, and the filing does not disclose GEOST's revenue, earnings, or the purchase price allocation, so investors cannot yet assess the acquisition's financial contribution from this document. Strategically, the acquisition adds payload capability to Rocket Lab's existing launch and spacecraft businesses. Management positions the company as a prime contractor for defense programs such as the Golden Dome concept and the Space Development Agency's Proliferated Warfighter Space Architecture, with GEOST's missile warning, tracking, ISR, and space domain awareness payloads as the new offering. GEOST is described as having over 100 employees and operations in Arizona and Virginia, and the company expects to use Rocket Lab's manufacturing resources to scale high-volume EO/IR production. From a capital perspective, the stock consideration is modest, roughly 3.06 million shares, and the company also filed a prospectus supplement registering the resale of those shares by the selling stockholder under an existing S-3ASR shelf. This creates a potential source of incremental supply in the market. Investors should weigh the cash outlay and possible earnout against integration execution risk and the eventual disclosure of GEOST's financial performance.

Aug 12, 2025 10-Q

Rocket Lab Quarterly Report for Q2 Ended Jun 30, 2025

Rocket Lab Corporation (RKLB) reported a strong increase in revenue for the second quarter and first half of 2025, with total revenues growing 36% year-over-year to $144.5 million for the quarter and 34% to $267.1 million for the first six months. This growth was primarily driven by robust performance in the Space Systems segment, fueled by satellite manufacturing, and a significant uptick in Launch Services revenue due to increased launch cadence and revenue from over-time recognized missions. Despite revenue growth, the company continued to experience operating losses, with a net loss of $66.4 million for the quarter and $127.0 million for the first six months, largely due to substantial investments in Research and Development, particularly for the Neutron launch vehicle. The company significantly strengthened its balance sheet, ending the quarter with $564.1 million in cash and cash equivalents and $185.2 million in marketable securities, a substantial increase from the prior year, bolstered by proceeds from an At-the-Market (ATM) Equity Offering. The backlog remained substantial at $995.4 million, with a significant portion expected to be recognized within the next 12 months. Management expressed confidence in their liquidity position, anticipating current cash and customer payments to be sufficient for at least the next twelve months, while also planning for further investments in production, product development, and potential acquisitions.

Aug 7, 2025 8-K

Rocket Lab 8-K Report, Financial Results (Aug 7, 2025)

Rocket Lab reported record second-quarter 2025 revenue of $144.5 million, up 36% year over year from $106.3 million. Gross margin expanded sharply: GAAP gross margin rose to about 32.1% from 25.6% a year earlier, and non-GAAP gross margin reached 36.9% versus 30.7%. Growth was driven by product revenue of $92.7 million and service revenue of $51.8 million, with five successful Electron launches in the quarter. Profitability remains elusive. The operating loss widened to $59.6 million from $43.3 million, as R&D (up about 66% to $66.1 million) and SG&A grew faster than gross profit. Net loss was $66.4 million, or $0.13 per share, and adjusted EBITDA was a loss of $27.6 million. The balance sheet strengthened materially during the first half, supported by about $397 million in gross proceeds from an at-the-market equity offering. Cash and equivalents reached $564 million, and including marketable securities, total liquidity was roughly $749 million. Management is guiding to third-quarter revenue of $145 million to $155 million, GAAP gross margin of 35% to 37%, and an adjusted EBITDA loss of $21 million to $23 million, which implies continued operating losses but some improvement in margin trajectory. Strategically, the company is pursuing growth beyond launch. It is acquiring Geost for $275 million in a cash-plus-equity deal, with a potential time-based revenue earnout of up to $50 million, to create a Payloads business unit aimed at defense satellite contracts. It also moved into production on an $515 million constellation build of 18 spacecraft for the Space Development Agency's Tranche 2 Transport Layer. Neutron's Launch Complex 3 is expected to open in Q3 2025. Investors should weigh strong top-line momentum and margin progress against widening losses, heavy R&D spending, and dilution from equity issuance and the pending acquisition.

Aug 7, 2025 8-K

Rocket Lab 8-K Report, Shareholder Nominations (Jun 9, 2025)

Rocket Lab Corporation has filed an 8-K detailing important dates for its 2025 annual meeting of stockholders. The company anticipates holding the meeting on August 27, 2025. Due to a significant shift in the meeting date compared to the previous year's meeting, Rocket Lab has established specific deadlines for stockholders wishing to submit proposals for inclusion in the proxy materials or to nominate directors. Investors looking to submit proposals for the 2025 Annual Meeting under Rule 14a-8 must ensure their proposals are received by the Company's Secretary by June 19, 2025. Similarly, any stockholder wishing to nominate a director or propose other business for consideration at the meeting, as outlined in the Company's bylaws, must also provide timely notice by the same June 19, 2025 deadline. Failure to meet these deadlines, along with compliance with all other bylaw and SEC requirements, may result in proposals or nominations not being considered at the meeting.

Jun 9, 2025 8-K

Rocket Lab 8-K Report, Material Agreement (May 27, 2025)

Rocket Lab Corporation (Nasdaq: RKLB) has agreed to acquire LightRidge Interco, the parent holding company of GEOST LLC, a Tucson, Arizona-based producer of electro-optical and infrared (EO/IR) payloads for U.S. national security satellites. Under the Stock Purchase Agreement signed May 22, 2025, the total consideration is $275 million: up to approximately $125 million in cash and up to approximately $150 million in Rocket Lab common stock, subject to customary closing adjustments. An additional earnout of up to $50 million in cash is tied to GEOST revenue targets for 2026 and 2027. The deal marks Rocket Lab's formal entry into the satellite payload segment, which management frames as a move toward vertically integrated, end-to-end national security space solutions. The transaction is subject to customary conditions, including expiration or termination of the HSR Act waiting period, and is expected to close in the second half of 2025. The stock consideration will be valued based on the closing price on the Nasdaq Capital Market the trading day before closing, subject to a base price floor condition. Rocket Lab has agreed to file a resale registration statement covering the shares issued in the deal, which could add selling pressure once the shares become registrable. The stock portion is being issued in a private placement under Section 4(a)(2) and/or Regulation D. The filing also discloses a holding company reorganization completed May 23, 2025, under which Rocket Lab Corporation, a Delaware corporation, became the successor issuer to Rocket Lab USA, Inc. The full Purchase Agreement will be filed as an exhibit to the next Form 10-Q, so investors should review it then for the complete terms, including adjustment mechanics and the earnout structure. Financial terms such as GEOST's revenue, earnings, and margins were not disclosed in this filing.

May 27, 2025 8-K

Rocket Lab 8-K Report, Financial Results (May 8, 2025)

Rocket Lab USA (RKLB) reported first-quarter 2025 revenue of $122.6 million, up 32% year over year from $92.8 million and at the top end of its guidance. Product revenue rose to $80.8 million from $54.1 million, while service revenue grew more modestly to $41.8 million from $38.6 million. Profitability weakened: GAAP gross margin was about 28.8% (up from 26.1%), but operating expenses rose 40% to $94.4 million, driven by research and development (up 43%) and selling, general and administrative costs (up 37%). The operating loss widened to $59.2 million, and the net loss was $60.6 million, or $0.12 per share, versus $44.3 million a year earlier. Adjusted EBITDA was a loss of $30.0 million. Operating cash flow was negative $54.2 million and capital expenditures were $28.7 million, implying free cash flow of roughly negative $83 million. The company raised about $92.8 million in gross proceeds through an at-the-market equity program and a $25 million secured term loan. Cash, cash equivalents and marketable securities totaled roughly $512 million at quarter-end, based on the balance sheet. For Q2 2025, management guided to revenue of $130 million to $140 million, GAAP gross margin of 30% to 32%, and an adjusted EBITDA loss of $28 million to $30 million. Stock-based compensation is expected at $13 million to $14 million. The guidance implies continued revenue growth alongside sustained operating losses. Strategically, the company announced a holding company reorganization, expected to be effective by June 1, 2025, in which Rocket Lab Corporation would become the new public parent. Shares would convert one-for-one, the stock would keep trading as RKLB on Nasdaq, and the reorganization is intended to be tax-free to shareholders and does not require a stockholder vote. The company also disclosed its pending acquisition of Mynaric, which would extend its presence into Europe, and its Neutron rocket's on-ramp to the Space Force's NSSL Phase 3 Lane 1 program. For investors, the central tension is strong top-line growth and expanding government and defense demand against rising operating losses, heavy investment in Neutron and new business lines, and continued reliance on capital markets to fund the cash burn. Execution on Neutron, margin improvement, and the Mynaric integration will be key items to monitor.

May 8, 2025 10-Q

Rocket Lab Quarterly Report for Q1 Ended Mar 31, 2025

Rocket Lab USA, Inc. (RKLB) reported a 32% year-over-year increase in total revenues for the first quarter of 2025, reaching $122.6 million, primarily driven by strong performance in its Space Systems segment. Despite this revenue growth, the company posted a net loss of $60.6 million for the quarter, an increase from the $44.3 million loss in the prior year, largely due to increased operating expenses, particularly in research and development for the Neutron launch vehicle and expansion of its spacecraft components portfolio. The company ended the quarter with a healthy cash position of $303.1 million, supplemented by $209.2 million in marketable securities, indicating sufficient liquidity for the next twelve months. Significant investments continue in the development of the Neutron launch vehicle and scaling production capabilities, which are key to the company's future growth strategy. Management remains focused on improving profit margins and expanding its market share in both launch services and space systems. Key developments include the ongoing progress on the Neutron vehicle, continued strength in Space Systems, and a substantial backlog of $1.07 billion. The company also noted the potential impact of recent U.S. trade policy shifts, including new tariffs, on its supply chain, although it has not been materially impacted to date.

May 8, 2025 10-K

Rocket Lab Annual Report (Amendment), Year Ended Dec 31, 2024

Rocket Lab Corporation's (RKLB) 10-K filing for the period ending December 31, 2024, provides an in-depth look at its corporate governance and executive compensation practices. The filing details the composition and responsibilities of its Board of Directors and various committees, emphasizing a commitment to independent oversight. Notably, all directors, except for the CEO Peter Beck, are deemed independent by Nasdaq and SEC standards. The report also thoroughly outlines the compensation philosophy and practices for its Named Executive Officers (NEOs), highlighting a performance-driven approach with a significant portion of compensation tied to variable and equity-based incentives. Significant executive compensation adjustments were made in 2024, particularly for CEO Peter Beck, reflecting a comprehensive review of his role and market positioning. This included a substantial base salary increase and significant RSU awards intended to ensure retention and align long-term interests. The company also detailed compensation for its Chief Operations Officer, Frank Klein, upon his appointment. The filing underscores Rocket Lab's strategy to attract, motivate, and retain top talent through competitive compensation structures, with a clear emphasis on aligning executive interests with those of its shareholders, as evidenced by the substantial equity grants and performance-based bonuses.

Apr 30, 2025 8-K

Rocket Lab 8-K Report, Regulation FD Disclosure (Mar 11, 2025)

On March 11, 2025, Rocket Lab USA, Inc. (Nasdaq: RKLB) entered into an ATM (at-the-market) Equity Offering Sales Agreement with BofA Securities, Cantor Fitzgerald & Co., Stifel, Nicolaus & Company, and TD Securities (USA) LLC. The agreement allows Rocket Lab to sell up to $500 million of its common stock from time to time through these sales agents, acting either as agents or as principal. The offering is made under an automatically effective Form S-3 shelf registration and a related prospectus supplement, both filed the same day. Rocket Lab is under no obligation to sell any shares, and either party may terminate the agreement at any time on written notice. The company stated that it intends to use any net proceeds to fund future growth, including potential acquisitions such as its announced intent to acquire laser communications provider Mynaric, as well as for general corporate and working capital purposes. Because the program is discretionary and the timing and size of sales will depend on factors set by the company, the filing does not commit Rocket Lab to any specific issuance. Investors should note that an ATM program creates the possibility of future dilution to existing shareholders, though the actual amount depends on how much stock is sold and at what prices. The filing is primarily a financing-capacity disclosure rather than a report of completed transactions. No shares had been sold as of the filing, and the 8-K does not disclose pricing, share counts, or the financial terms of the Mynaric acquisition. Investors should review the prospectus supplement and the company's Form 10-K for the year ended December 31, 2024 for risk factors and more complete information.

Mar 11, 2025 8-K

Rocket Lab 8-K Report, Financial Results (Feb 27, 2025)

Rocket Lab reported record full-year 2024 revenue of $436.2 million, up 78% from $244.6 million in 2023, and record fourth-quarter revenue of $132.4 million, up 121% year over year from $60.0 million. Growth was driven by both segments: service revenue rose to $48.4 million in Q4 from $12.1 million, and product revenue rose to $84.0 million from $47.9 million. Profitability improved but remains negative. Q4 GAAP gross margin was about 27.8% (non-GAAP 34.0%), and GAAP operating loss narrowed to $51.5 million from $47.9 million, though it widened slightly year over year. Full-year net loss was $190.2 million, or $0.38 per share, and Adjusted EBITDA loss improved to $96.9 million from $90.9 million. The balance sheet shows roughly $480 million in cash and marketable securities at year-end, including $271.0 million in cash, $147.9 million in current marketable securities and $60.7 million in non-current marketable securities. Against this, the company carries $345.4 million in net convertible senior notes issued in 2024. Operating cash burn was $48.9 million for the year, and capital expenditures were $67.1 million. Management guided Q1 2025 revenue to $117 million to $123 million, which implies a sequential decline from Q4, with Adjusted EBITDA loss of $33 million to $35 million. Management also highlighted more than $450 million in new contracts, 16 Electron launches in 2024, and a planned second-half 2025 debut of the Neutron rocket. For investors, the key question is whether revenue momentum and contract backlog can translate into margin expansion and sustained cash generation as the company scales. The Q1 guidance decline, continued operating losses and the Neutron debut timing are the main near-term watch items. This filing is furnished under Item 2.02 and is not deemed filed for Section 18 liability purposes.

Feb 27, 2025 10-K

Rocket Lab Annual Report, Year Ended Dec 31, 2024

Rocket Lab USA, Inc. (RKLB) has demonstrated significant revenue growth in the fiscal year 2024, with a 78% increase to $436.2 million, driven by strong performance in both its launch services and space systems segments. The company launched 16 Electron rockets in 2024, a notable increase from the previous year, establishing itself as a frequent global launcher. The space systems segment also saw substantial growth, largely due to spacecraft manufacturing. The company continues to invest heavily in research and development, particularly for its upcoming Neutron medium-lift launch vehicle, with a planned debut launch in the second half of 2025. While the company remains unprofitable, reporting a net loss of $190.2 million for 2024, the growth in revenue and improvement in gross profit margins indicate positive operational momentum. Rocket Lab's strategy focuses on vertically integrated end-to-end space solutions, from launch to on-orbit management, aiming to capture a larger share of the growing space economy.

Feb 27, 2025 8-K

Rocket Lab 8-K Report, Rights Modification (Jan 10, 2025)

Rocket Lab USA, Inc. (RKLB) announced the consummation of a Preferred Stock Exchange on January 7, 2025, where 50,951,250 shares of common stock held by The Equatorial Trust, a family trust established by founder Sir Peter Beck, were exchanged for an equal number of shares of Series A Convertible Participating Preferred Stock. This exchange, previously disclosed, has now been finalized with the filing of the Certificate of Designation. The preferred stock carries specific conversion rights and automatic conversion triggers, including events related to Sir Peter Beck's role within the company and his beneficial ownership levels. It also grants the holders, voting as a separate class, the right to elect at least one director to the Company's Board and additional directors if the Board size increases significantly. The preferred stock has a nominal liquidation preference but participates alongside common stockholders in residual assets.

Jan 10, 2025 8-K

Rocket Lab 8-K Report, Material Agreement (Dec 5, 2024)

Rocket Lab Corp (RKLB) filed an 8-K on December 5, 2024, detailing a material definitive agreement concerning an exchange of shares. The company entered into an Exchange Agreement with The Equatorial Trust, whereby the Trust will exchange 50,951,250 shares of RKLB Common Stock, beneficially owned by Sir Peter Beck, for an equivalent number of shares of a new series of Preferred Stock. This transaction is expected to close in early 2025 and is subject to customary closing conditions, including Hart-Scott-Rodino Act waiting periods. The newly issued Preferred Stock carries significant rights and features designed to align with Sir Peter Beck's continued leadership and influence within the company. Key among these is the conversion feature, which allows the Preferred Stock to convert into Common Stock under various circumstances, including Sir Peter's departure from executive roles or upon certain ownership thresholds being met. Furthermore, holders of the Preferred Stock will have the right to designate at least one director to the RKLB Board, with Sir Peter Beck slated to be the initial Preferred Stock Director. This exchange, alongside an amended and restated employment agreement for Sir Peter Beck, underscores a strategic effort to secure leadership continuity and executive compensation while introducing a structured mechanism for potential future equity shifts.

Dec 5, 2024 8-K

Rocket Lab 8-K Report, Regulation FD Disclosure (Nov 29, 2024)

Rocket Lab USA (RKLB) disclosed in this Form 8-K, filed November 29, 2024, that its wholly-owned subsidiary SolAero Technologies Corp. entered into a Direct Funding Agreement with the U.S. Department of Commerce on November 22, 2024. Under the CHIPS and Science Act, SolAero may receive up to $23.9 million in funding to expand compound semiconductor manufacturing at its Albuquerque, New Mexico facility, which produces space-grade solar cells. Funds will be disbursed against a milestone schedule tied to project phases. The press release furnished as Exhibit 99.1 (dated November 25, 2024) describes this as finalizing an award that followed a preliminary term sheet earlier in 2024. The funding is not free capital. Rocket Lab guaranteed SolAero's obligations under the Funding Agreement and committed to contribute at least $32 million of equity to SolAero over time so the project can be completed. The filing also imposes operating restrictions on both the company and SolAero: SolAero cannot enter certain partnerships, joint ventures, or mergers, acquire certain equity interests, dispose of certain property, or make certain capital contributions without the Department's prior written consent. Absent exceptions, the parent company also cannot conduct stock buybacks or pay dividends without that consent. Assets acquired or improved with Award Funds must be held in trust for the Department. For investors, the event is modest in size relative to Rocket Lab's overall business, but it carries a meaningful commitment: the $32 million equity contribution is larger than the award itself, and the restrictions constrain capital allocation and corporate flexibility for the duration of the project. The filing is a Regulation FD disclosure and a material-agreement disclosure rather than a change in financial results. The main benefits are expanded capacity in one of only two U.S. producers of radiation-hardened space-grade solar cells, supporting national security and commercial satellite demand.

Nov 29, 2024 8-K

Rocket Lab 8-K Report, Financial Results (Nov 12, 2024)

Rocket Lab USA (RKLB) reported third-quarter 2024 results on November 12, 2024 (furnished under Item 2.02 with press release Exhibit 99.1). Revenue rose 55% year-over-year to $104.8 million, up from $67.7 million, and nine-month revenue reached $303.8 million. Gross profit was $28.0 million (26.7% GAAP gross margin), but the company remained unprofitable: GAAP operating loss widened to $51.9 million and net loss was $51.9 million, or $(0.10) per share. Adjusted EBITDA was a loss of $30.9 million, compared with a $15.5 million loss a year earlier. Operating expenses rose sharply as R&D nearly doubled to $47.7 million, reflecting Neutron development and Archimedes engine testing. Balance sheet liquidity improved materially during the period. Cash and cash equivalents rose to $292.5 million, and total cash plus marketable securities (current and non-current) was roughly $504 million, versus about $324 million at year-end 2023. The company issued $355 million of convertible senior notes and used part of the proceeds to repay the $48.9 million Trinity Loan and purchase capped calls. Total liabilities increased to $733 million, largely due to the convertible notes, and stockholders' equity fell to $420 million from $555 million as the accumulated deficit grew. Operating cash burn was $46.5 million over nine months, and capital expenditures were $45.5 million. Management highlighted a record backlog of $1.05 billion, 12 Electron launches year-to-date (a company record), $55 million in new Electron contracts, and a Neutron launch services agreement with a confidential constellation customer. Guidance for Q4 2024 calls for revenue of $125 million to $135 million, GAAP gross margin of 26% to 28%, and adjusted EBITDA loss of $27 million to $29 million. Investors should weigh strong top-line growth and backlog against a persistent operating loss, rising R&D spending, and dilution risk from the convertible notes.

Nov 12, 2024 10-Q

Rocket Lab Quarterly Report for Q3 Ended Sep 30, 2024

Rocket Lab Corporation (RKLB) reported significant revenue growth in its third quarter and first nine months of 2024, with total revenues increasing by 55% and 65% year-over-year, respectively. This growth was primarily driven by a strong performance in the Space Systems segment, which saw an 81% increase in revenue for the quarter and 82% for the nine-month period. While the Launch Services segment experienced a slight dip in quarterly revenue, it saw growth over the nine-month period due to increased launch cadence and higher revenue per launch. The company continues to invest heavily in research and development, particularly for its Neutron launch vehicle, leading to a substantial increase in R&D expenses. Despite the revenue growth, Rocket Lab reported net losses for both periods, though the net loss as a percentage of revenue decreased compared to the prior year. The company successfully raised significant capital through the issuance of convertible senior notes in February 2024, bolstering its cash position to $292.5 million in cash and cash equivalents and $211.2 million in marketable securities as of September 30, 2024. This financial strength is crucial as Rocket Lab continues to scale its operations, develop new technologies, and expand its market reach in both launch services and space systems.

Nov 12, 2024 8-K

Rocket Lab 8-K Report, Executive Changes (Sep 16, 2024)

This 8-K filing from Rocket Lab USA, Inc. (RKLB) reports the immediate resignation of Michael Griffin from its Board of Directors, effective September 12, 2024. Mr. Griffin's departure is stated to be for retirement and is not attributed to any disagreements with the company regarding its operations, policies, or practices. The company expressed gratitude for his contributions and insights during his tenure. While the departure of a board member is noteworthy, the filing explicitly states it's for retirement and amicable. Investors should focus on Rocket Lab's ongoing operational performance and strategic initiatives, as this filing does not indicate any material disruption to the company's business or governance structure. Further details on board composition and future appointments, if any, will be key areas to monitor.

Sep 16, 2024 8-K

Rocket Lab 8-K Report, Executive Changes (Sep 10, 2024)

Rocket Lab USA, Inc. (Nasdaq: RKLB) filed an 8-K on September 10, 2024 announcing the appointment of Frank Klein as Chief Operations Officer, effective September 16, 2024. Klein brings more than 30 years of manufacturing and operations experience, most recently as COO of Rivian Automotive (2022–2024), where he oversaw 9,000+ employees, and previously as President of Magna Steyr AG and a 27-year veteran of Daimler AG. His mandate is to scale production of spacecraft, launch vehicles, and spacecraft components to meet a backlog of more than $1 billion in orders. The filing's compensation package is the key item for investors to note. Klein receives a $400,000 base salary, a discretionary annual bonus of up to 70% of base, a $100,000 sign-on bonus, and 1,300,000 restricted stock units vesting over four years. The RSU grant is the most material element, and its dilution impact depends on the company's share count, which is not disclosed in this filing. He is also covered under the Tier 2 Executive Severance Plan and will enter the company's standard indemnification agreement. The filing reports no related-party transactions involving Klein above $120,000. The appointment is a leadership addition rather than a financial event, and the filing contains no financial results or guidance. CEO Sir Peter Beck tied the hire to Electron launch cadence growth, the operationalization of Neutron, and a path to profitability for the satellite and space systems divisions. Investors should view the appointment as a signal of intent to professionalize manufacturing at scale, with execution against those goals as the real test over time.

Sep 10, 2024 8-K

Rocket Lab 8-K Report, Executive Changes (Aug 23, 2024)

Rocket Lab USA, Inc. (Nasdaq: RKLB) filed this Form 8-K to disclose a board change: on August 21, 2024, the Board expanded from eight to nine directors and appointed Kenneth Possenriede as a Class III director to fill the newly created vacancy, with a term expiring at the 2027 annual meeting. The Company has determined he is independent under Nasdaq listing standards, and he was also named to the Audit Committee. Investors should note the appointment strengthens the Board's financial oversight, since Possenriede is a former Lockheed Martin EVP and CFO (2019 to 2021) with a background in treasury, capital markets, and program finance. The filing does not disclose any financial results, guidance, or operating metrics, so it is a governance event rather than a performance catalyst. Compensation terms follow the Company's standard non-employee director policy. He receives a prorated 2024 cash retainer, a one-time initial RSU grant valued at $360,000 vesting in three equal annual installments, and an annual RSU grant valued at $180,000 (or a pro-rata portion at the next annual meeting). All equity awards accelerate in full upon a sale of the Company. He will also enter into the Company's standard indemnification agreement. The filing reports no related-party transactions over $120,000 involving him and no arrangements under which he was selected. The accompanying press release (Exhibit 99.1, dated August 22, 2024) emphasizes his aerospace and defense experience and Rocket Lab's positioning as an end-to-end space company, citing Electron, the space systems business, and Neutron development. These are company characterizations rather than audited data. Overall, the filing is a routine director appointment with modest dilution implications limited to the standard equity grants, and its main significance is the added financial expertise on the Board and Audit Committee.

Aug 23, 2024 8-K

Rocket Lab 8-K Report, Financial Results (Aug 8, 2024)

Rocket Lab reported record second-quarter 2024 revenue of $106.3 million, up 71% from $62.0 million a year earlier, driven by growth in both Launch Services and Space Systems. Net loss narrowed to $41.6 million from $45.9 million, and Adjusted EBITDA loss widened slightly to $21.2 million from $20.2 million. GAAP gross margin improved to about 25.6% from about 23.5%, and non-GAAP gross margin was 30.7%, down from 31.8% a year earlier. Operating expenses rose to $70.4 million, led by a 29% increase in research and development spending tied to the Neutron program. The balance sheet strengthened materially during the period. Rocket Lab issued $355 million of convertible senior notes due to fund operations and repaid $45.8 million under its Trinity loan. Cash, cash equivalents and marketable securities totaled roughly $543 million at June 30, 2024, up from about $324 million at year-end 2023, and contract liabilities grew to $184 million, indicating strong forward bookings. Management also reported more than $720 million in spacecraft under contract and 17 new launch contracts signed year-to-date. The third-quarter guidance is the key point for investors. Revenue of $100 million to $105 million implies a sequential decline from Q2, and the company expects Adjusted EBITDA loss of $31 million to $33 million, wider than Q2's $21 million loss, with GAAP operating expenses of $80 million to $82 million. Investors will be focused on Neutron development milestones, the timing of the first Neutron flight, and whether the company can reach profitability as its Launch Services and Space Systems revenue scales.

Aug 8, 2024 10-Q

Rocket Lab Quarterly Report for Q2 Ended Jun 30, 2024

Rocket Lab Corporation (RKLB) reported a significant increase in revenue for the quarter ended June 30, 2024, up 71% year-over-year to $106.3 million, driven by strong performance in both its Launch Services and Space Systems segments. The Space Systems segment, in particular, saw a 94% increase in revenue. Despite revenue growth, the company reported a net loss of $41.6 million for the quarter, though this represents an improvement from the prior year's loss of $45.9 million. The company's balance sheet reflects a substantial increase in cash and cash equivalents to $340.9 million, bolstered by proceeds from the issuance of convertible senior notes. Rocket Lab also announced a significant ten-launch agreement with Synspective and progress on its Neutron launch vehicle development. The company's strategic focus on expanding its launch capabilities with the Neutron vehicle and growing its Space Systems business is evident in the increased investment in research and development. While operating expenses also rose, they grew at a slower pace than revenue, leading to improved gross profit margins. Investors will be watching for continued revenue acceleration, progress on the Neutron program, and the company's path towards profitability.

Aug 8, 2024 8-K

Rocket Lab 8-K Report, Shareholder Vote Results (Jun 14, 2024)

Rocket Lab USA, Inc. (RKLB) filed an 8-K on June 14, 2024, detailing the results of its 2024 Annual Meeting of Stockholders held on June 12, 2024. The meeting saw strong participation with over 71% of outstanding shares represented. Key outcomes included the election of two Class III directors, Lt. Gen. Nina M. Armagno (Ret.) and Peter Beck, to serve three-year terms. Both directors received substantial support from stockholders, indicating confidence in their leadership and the company's direction. Furthermore, the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, was overwhelmingly ratified by the stockholders. Finally, the compensation of the company's named executive officers was approved on an advisory basis, with a significant majority of votes cast in favor. These outcomes reflect general stockholder approval of the company's governance and executive compensation practices.

Jun 14, 2024 10-Q

Rocket Lab Quarterly Report for Q1 Ended Mar 31, 2024

Rocket Lab USA, Inc. (RKLB) reported a strong revenue increase of 69% year-over-year for the first quarter of 2024, reaching $92.8 million, driven by significant growth in both its Launch Services and Space Systems segments. Despite this impressive top-line performance, the company continued to experience an operating loss, though it narrowed compared to the prior year. The company significantly bolstered its cash position through a substantial issuance of convertible senior notes, providing capital for ongoing development and operations. Key financial developments include a notable increase in cash and cash equivalents, largely attributable to the $355 million raised from convertible senior notes. However, the company also saw an increase in R&D expenses, reflecting continued investment in the Neutron launch vehicle and expanding space systems capabilities. The company ended the quarter with a backlog of $1,015.3 million, indicating substantial future revenue potential, with a significant portion expected within the next 12 months.

May 6, 2024 8-K

Rocket Lab 8-K Report, Financial Results (May 6, 2024)

Rocket Lab reported first-quarter 2024 revenue of $92.8 million, up 69% year over year from $54.9 million and up roughly 55% sequentially per the company's headline. Gross profit rose to $24.2 million (GAAP gross margin about 26%, non-GAAP gross margin 31.7%, versus 17.9% a year earlier). Operating loss narrowed to $43.1 million from $46.0 million, and net loss was $44.3 million, or $0.09 per share, compared with $45.6 million a year earlier. Adjusted EBITDA improved to a loss of $21.7 million from $26.2 million. Revenue growth and margin expansion were the main positives, though the company remains unprofitable. The balance sheet changed materially. Rocket Lab issued $355 million of convertible senior notes, bought $43.2 million of capped calls, and repaid $43.2 million of its Trinity loan. Cash, cash equivalents and marketable securities total about $561 million, up from roughly $325 million at year-end 2023. Total liabilities rose to $703 million from $387 million, driven mainly by the $344 million net carrying value of the notes. Operating cash burn was small in the quarter ($2.6 million used in operations), but capital expenditures of $19.2 million continue to rise as the company builds out Neutron. Management cited a backlog above $1 billion and guided second-quarter 2024 revenue to $105 million to $110 million, with adjusted EBITDA loss of $23 million to $25 million. The company also pushed its Neutron medium-lift rocket's first launch target to no earlier than mid-2025, citing the new schedule after the first complete Archimedes engine was assembled. Investors should weigh the strong growth and funded balance sheet against continued losses, the convertible debt, and execution risk on Neutron and the $515 million Space Development Agency program.

May 6, 2024